Stereoselectivity in the human metabolism of methamphetamine

British Journal of Clinical Pharmacology

Volumn 69, Issue 2, 2010, Pages 187-192

  Li, Linghui ^a   Everhart, Tom ^b   Jacob Iii, Peyton ^b   Jones, Reese ^b   Mendelson, John ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Metabolism; Methamphetamine; Stereoselectivity

Indexed keywords

AMPHETAMINE; DRUG METABOLITE; HYDROXYMETHAMPHETAMINE; METHAMPHETAMINE; PLACEBO; UNCLASSIFIED DRUG; CENTRAL STIMULANT AGENT;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG URINE LEVEL; ENANTIOSELECTIVITY; GAS CHROMATOGRAPHY; HUMAN; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STEREOCHEMISTRY; ANALYSIS OF VARIANCE; CHEMISTRY; MASS FRAGMENTOGRAPHY; METABOLIC CLEARANCE RATE; METABOLISM; MIDDLE AGED; STEREOISOMERISM; URINE; YOUNG ADULT;

ADULT; ANALYSIS OF VARIANCE; CENTRAL NERVOUS SYSTEM STIMULANTS; DOUBLE-BLIND METHOD; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; METABOLIC CLEARANCE RATE; METHAMPHETAMINE; MIDDLE AGED; STEREOISOMERISM; YOUNG ADULT;

EID: 75149161719     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2009.03576.x     Document Type: Article

References (17)

1. Physician's Desk Reference, 54 edn. Montvale, NJ : Medical Economics Company, 2000.
2. Mendelson J, Uemura N, Harris D, Nath RP, Fernandez E, Jacob P, Everhart T, Jones RT. Human pharmacology of the methamphetamine stereoisomers. Clin Pharmacol Ther 2006 80 : 403 420.
3. Lin LY, Di Stefano EW, Schmitz DA, Hsu L, Ellis SW, Lennard MS, Tucker GT, Cho AK. Oxidation of methamphetamine and methylenedioxymethamphetamine by CYP2D6. Drug Metab Dispos 1997 25 : 1059 1064.
4. Baselt R. Disposition of Toxic Drugs and Chemicals in Man, 2nd edn. Foster City, CA : Biomedical Publications, 1978.
5. Beckett AH, Rowland M. Urinary excretion of methylamphetamine in man. Nature 1965 206 : 1260 1261.
6. Cook CE, Jeffcoat AR, Hill JM, Pugh DE, Patetta PK, Sadler BM, White WR, Perez-Reyes M. Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride. Drug Metab Dispos 1993 21 : 717 723.
7. Cook CE, Jeffcoat AR, Sadler BM, Hill JM, Voyksner RD, Pugh DE, White WR, Perez-Reyes M. Pharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humans. Drug Metab Dispos 1992 20 : 856 862.
8. Caldwell J, Dring LG, Williams RT. Metabolism of (14 C)methamphetamine in man, the guinea pig and the rat. Biochem J 1972 129 : 11 22.
9. Oyler JM, Cone EJ, Joseph RE Jr., Moolchan ET, Huestis MA. Duration of detectable methamphetamine and amphetamine excretion in urine after controlled oral administration of methamphetamine to humans. Clin Chem 2002 48 : 1703 1714.
10. Gunne LM. The urinary output of d- and l-amphetamine in man. Biochem Pharmacol 1967 16 : 863 869.
11. Beckett AH, Brookes LG, Shenoy EV. Urinary excretion of the drug and its main metabolite in man, after the administration of (plus or minus)-, (plus)- and (minus)-ethylamphetamine. J Pharm Pharmacol 1969 21 (Suppl. 151S+.
12. Meyer MR, Peters FT, Maurer HH. The role of human hepatic cytochrome P450 isozymes in the metabolism of racemic 3,4-methylenedioxy-methamphetamine and its enantiomers. Drug Metab Dispos 2008 36 : 2345 2354.
13. Kim I, Oyler JM, Moolchan ET, Cone EJ, Huestis MA. Urinary pharmacokinetics of methamphetamine and its metabolite, amphetamine following controlled oral administration to humans. Ther Drug Monit 2004 26 : 664 672.
14. Huestis MA, Cone EJ. Methamphetamine disposition in oral fluid, plasma, and urine. Ann NY Acad Sci 2007 1098 : 104 121.
15. Lind AB, Reis M, Bengtsson F, Jonzier-Perey M, Powell Golay K, Ahlner J, Baumann P, Dahl ML. Steady-state concentrations of mirtazapine, N-desmethylmirtazapine, 8-hydroxymirtazapine and their enantiomers in relation to cytochrome P450 2D6 genotype, age and smoking behaviour. Clin Pharmacokinet 2009 48 : 63 70.
16. Cody JT, Schwarzhoff R. Interpretation of methamphetamine and amphetamine enantiomer data. J Anal Toxicol 1993 17 : 321 326.
17. Musshoff F. Illegal or legitimate use? Precursor compounds to amphetamine and methamphetamine. Drug Metab Rev 2000 32 : 15 44.